Walleye Trading
CLB icon

Walleye Trading’s Core Laboratories CLB Stock Holding History

Walleye Trading’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$124K – 4386
2025
Q3 		$124K Sell
10,000
-5,900
-37% -$69.2K ﹤0.01% 3628
2025
Q2 		$183K Buy
+15,900
New +$189K ﹤0.01% 3287
2024
Q3 		– Sell
-18,000
Closed -$365K – 4153
2024
Q2 		$365K Buy
18,000
+2,000
+13% +$35.4K ﹤0.01% 2732
2024
Q1 		$273K Sell
16,000
-5,500
-26% -$86.5K ﹤0.01% 3248
2023
Q4 		$380K Buy
+21,500
New +$433K ﹤0.01% 3304
2023
Q3 		– Sell
-9,600
Closed -$223K – 5030
2023
Q2 		$223K Sell
9,600
-3,900
-29% -$88.2K ﹤0.01% 3359
2023
Q1 		$298K Buy
+13,500
New +$316K ﹤0.01% 3222
2022
Q4 		– Sell
-10,000
Closed -$135K – 5002
2022
Q3 		$135K Buy
+10,000
New +$169K ﹤0.01% 3932
2021
Q4 		– Sell
-14,100
Closed -$391K – 5397
2021
Q3 		$391K Buy
14,100
+5,700
+68% +$174K ﹤0.01% 3176
2021
Q2 		$327K Sell
8,400
-32,100
-79% -$1.15M ﹤0.01% 3398
2021
Q1 		$1.17M Buy
40,500
+23,300
+135% +$796K 0.01% 1772
2020
Q4 		$456K Buy
+17,200
New +$351K ﹤0.01% 2733
2020
Q3 		– Sell
-9,100
Closed -$185K – 4159
2020
Q2 		$185K Buy
9,100
+8,600
+1,720% +$154K ﹤0.01% 3121
2020
Q1 		$5K Sell
500
-56,300
-99% -$1.57M ﹤0.01% 3795
2019
Q4 		$2.14M Sell
56,800
-43,200
-43% -$1.94M 0.01% 1181
2019
Q3 		$4.66M Buy
100,000
+60,300
+152% +$2.8M 0.04% 498
2019
Q2 		$2.08M Buy
39,700
+36,600
+1,181% +$2.15M 0.02% 1017
2019
Q1 		$214K Buy
3,100
+1,600
+107% +$107K ﹤0.01% 2967
2018
Q4 		$89K Sell
1,500
-7,300
-83% -$630K ﹤0.01% 3940
2018
Q3 		$1.02M Buy
8,800
+5,300
+151% +$598K 0.01% 2044
2018
Q2 		$442K Buy
3,500
+300
+9% +$36.5K ﹤0.01% 2961
2018
Q1 		$346K Buy
3,200
+400
+14% +$44.3K ﹤0.01% 3031
2017
Q4 		$308 Sell
2,800
-22,800
-89% -$2.28M ﹤0.01% 3067
2017
Q3 		$2.53K Buy
25,600
+23,700
+1,247% +$2.3M 0.01% 1109
2017
Q2 		$192 Sell
1,900
-14,200
-88% -$1.53M ﹤0.01% 3140
2017
Q1 		$1.86K Sell
16,100
-2,900
-15% -$337K 0.01% 1146
2016
Q4 		$2.28M Buy
19,000
+15,000
+375% +$1.66M 0.02% 878
2016
Q3 		$447K Sell
4,000
-32,300
-89% -$3.72M ﹤0.01% 2215
2016
Q2 		$4.5M Sell
36,300
-116,400
-76% -$14.1M 0.03% 492
2016
Q1 		$17.2M Buy
152,700
+16,200
+12% +$1.68M 0.15% 100
2015
Q4 		$14.8M Buy
136,500
+133,800
+4,956% +$15.3M 0.14% 119
2015
Q3 		$270K Sell
2,700
-3,700
-58% -$402K ﹤0.01% 2080
2015
Q2 		$730K Buy
6,400
+3,400
+113% +$412K 0.01% 1364
2015
Q1 		$313K Sell
3,000
-2,100
-41% -$224K ﹤0.01% 1855
2014
Q4 		$613K Sell
5,100
-2,000
-28% -$263K 0.01% 1405
2014
Q3 		$1.04M Buy
7,100
+5,700
+407% +$880K 0.01% 798
2014
Q2 		$233 Sell
1,400
-200
-13% -$35.6K ﹤0.01% 1880
2014
Q1 		$318 Sell
1,600
-600
-27% -$113K ﹤0.01% 1599
2013
Q4 		$420K Buy
+2,200
New +$409K ﹤0.01% 1667

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Trading's CLB Position: Q4 2021 in Review

Walleye Trading sold out of Core Laboratories (CLB) in Q4 2021, closing a stake of 5,424 shares — an estimated $151K sold.

Walleye Trading first reported a position in CLB in Q2 2013 and held it in 14 quarters. The position peaked at $970K in Q3 2014. 174 funds tracked by Wall St. Rank hold CLB as of Q4 2021.

  • Walleye Trading reported no remaining Core Laboratories position as of Q4 2021 after selling out during the quarter.
  • Walleye Trading sold 5,424 Core Laboratories shares in Q4 2021, an estimated $151K.
  • Walleye Trading first reported a position in Core Laboratories in Q2 2013 and held it in 14 quarters.
  • Walleye Trading's Core Laboratories position peaked at $970K in Q3 2014.
  • 174 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.

Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.